NASDAQ:NRC

National Research - NRC Stock Forecast, Price & News

$37.77

+0.49 (+1.31%)

(As of 11/25/2022 08:58 PM ET)

Add

Compare

Today's Range: $37.37
▼
$37.77
50-Day Range: $35.23
▼
$41.21
52-Week Range: $30.93
▼
$44.05

Volume: 11,400 shs
Average Volume: 42,764 shs
Market Capitalization: $932.58 million

P/E Ratio: 27.37
Dividend Yield: 2.54%
Price Target: N/A

National Research MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.63% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.11
Based on 3 Articles This Week
Insider Trading: Selling Shares
$9.82 M Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Business Services Sector

238th out of 329 stocks

Commercial Physical Research Industry

16th out of 16 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for National Research.

4.0

Short Interest

Percentage of Shares Shorted
1.63% of the float of National Research has been sold short.
Short Interest Ratio / Days to Cover
National Research has a short interest ratio ("days to cover") of 5.2.
Change versus previous month
Short interest in National Research has recently decreased by 28.09%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
National Research pays a meaningful dividend of 2.54%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
National Research does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of National Research is 69.57%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NRC.

1.7

News and Social Media Coverage

News Sentiment
National Research has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for National Research this week, compared to 2 articles on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, National Research insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,822,462.00 in company stock.
Percentage Held by Insiders
Only 2.00% of the stock of National Research is held by insiders.
Percentage Held by Institutions
67.51% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of National Research is 27.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.33.
Price to Earnings Ratio vs. Sector
The P/E ratio of National Research is 27.37, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 234.00.
Price to Book Value per Share Ratio
National Research has a P/B Ratio of 13.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About National Research (NASDAQ:NRC) Stock

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Stock News Headlines

November 28, 2022 | msn.com

Himalayan Yak Food Animal Tag FSSAI Himalayan yak Scientific name benefits of yak milk

November 25, 2022 | msn.com

Terms of Trade | The pitfalls of gerrymandering history

November 17, 2022 | finance.yahoo.com

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

November 15, 2022 | msn.com

Dearborn company fined for selling radioactive products

November 9, 2022 | finance.yahoo.com

National Research Third Quarter 2022 Earnings: EPS: US$0.34 (vs US$0.38 in 3Q 2021)

November 6, 2022 | seekingalpha.com

National Research Corporation (NRC) Q3 2022 Results - Earnings Call Transcript

November 2, 2022 | benzinga.com

National Research 10% Owner Sold $2.54M In Company Stock

November 1, 2022 | benzinga.com

National Research Corporation Announces Third Quarter 2022 Results

November 1, 2022 | finance.yahoo.com

National Research Corporation Announces Third Quarter 2022 Results

November 1, 2022 | finance.yahoo.com

NRC Health Study Finds Trust in Local Hospitals and Health Systems Increased During the Pandemic

October 25, 2022 | benzinga.com

Massive Insider Trade At National Research

October 19, 2022 | finance.yahoo.com

National Research Corporation to Broadcast its 2022 Third Quarter Conference Call Live on the Internet

October 17, 2022 | nz.finance.yahoo.com

Qu Biologics to Receive Additional Funding to Support Innovative New Treatment to Restore Innate Immune Function in the Elderly

October 13, 2022 | finance.yahoo.com

Joint UBC and Clear Seas Study to Provide Path to Zero-Impact Marine Shipping

October 13, 2022 | msn.com

Federal government eyeing nuclear repository in Carlsbad for new kinds of waste

September 26, 2022 | msn.com

Indore: Government approves 3 species recommended by IISR

September 17, 2022 | wsj.com

National Research Corp.

September 8, 2022 | reuters.com

National Research Corp

September 6, 2022 | benzinga.com

INTERNATIONAL AEROSPACE WEEK - MONTRÉAL 2022 - Québec's aerospace industry accelerates its shift towards sustainable mobility

September 1, 2022 | bizjournals.com

University of Pittsburgh receives 12 international studies awards

August 20, 2022 | msn.com

Two years after Trudeau promised a made-in-Canada COVID vaccine, the country is still waiting

August 19, 2022 | nasdaq.com

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

August 16, 2022 | finance.yahoo.com

NRC Health Unveils Winners of 2022 Annual Awards Programs

August 10, 2022 | uk.finance.yahoo.com

NuScale Power Reports Second Quarter 2022 Results and Reaffirms Financial Outlook

August 2, 2022 | finance.yahoo.com

National Research Corporation Announces Second Quarter 2022 Results

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Company Calendar

Last Earnings: 2/11/2020
Ex-Dividend for 10/14 Dividend: 9/29/2022
Dividend Payable: 10/14/2022
Today: 11/27/2022
Ex-Dividend for 1/13 Dividend: 12/29/2022
Fiscal Year End: 12/31/2022
Dividend Payable: 1/13/2023
Next Earnings (Estimated): 2/14/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NASDAQ:NRC
CUSIP: N/A
CIK: 70487
Web: www.nrchealth.com
Phone: (402) 475-2525
Fax: 402-475-9061
Employees: 511
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $1.38
Trailing P/E Ratio: 27.37
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $37.47 million
Net Margins: 22.93%
Pretax Margin: 30.21%
Return on Equity: 45.90%
Return on Assets: 23.92%

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 1.20
Quick Ratio: 1.20

Sales & Book Value

Annual Sales: $147.95 million
Price / Sales: 6.30
Cash Flow: $1.73 per share
Price / Cash Flow: 21.85
Book Value: $3.36 per share
Price / Book: 11.24

Miscellaneous

Outstanding Shares: 24,691,000
Free Float: 24,197,000
Market Cap: $932.58 million
Optionable: Not Optionable
Beta: 0.50

Key Executives

Mr. Michael D. Hays (Age 67)
Founder, CEO, Pres & Director
Comp: $167.5k

Mr. Kevin R. Karas CPA (Age 64)
CPA, Sr. VP of Fin., CFO, Treasurer & Sec.
Comp: $371.6k

Ms. Jona S. Raasch (Age 63)
Chief Operating Officer
Comp: $389.35k

Ms. Helen L. Hrdy (Age 57)
Chief Growth Officer
Comp: $371.74k

Mr. Jon Boumstein
Chief Delivery Officer

Dr. Gregory Makoul M.S.
Ph.D., Chief Transformation Officer

Linda Stacy
VP of Fin.

Megan Charko
Sr. Mang. of Content Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NRC Stock - Frequently Asked Questions

How have NRC shares performed in 2022?: National Research's stock was trading at $41.52 at the start of the year. Since then, NRC shares have decreased by 9.0% and is now trading at $37.77.
View the best growth stocks for 2022 here.
When is National Research's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our NRC earnings forecast.
How were National Research's earnings last quarter?: National Research Co. (NASDAQ:NRC) announced its earnings results on Tuesday, February, 11th. The company reported $0.34 earnings per share for the quarter. The firm had revenue of $32.62 million for the quarter. National Research had a net margin of 22.93% and a trailing twelve-month return on equity of 45.90%.
How often does National Research pay dividends? What is the dividend yield for National Research?: National Research declared a quarterly dividend on Friday, November 11th. Investors of record on Friday, December 30th will be paid a dividend of $0.12 per share on Friday, January 13th. This represents a $0.48 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Thursday, December 29th.
Read our dividend analysis for NRC.
Is National Research a good dividend stock?: National Research (NASDAQ:NRC) pays an annual dividend of $0.96 per share and currently has a dividend yield of 2.54%. The dividend payout ratio is 69.57%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.
What is Michael D. Hays' approval rating as National Research's CEO?: 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?: Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).
What is National Research's stock symbol?: National Research trades on the NASDAQ under the ticker symbol "NRC."
Who are National Research's major shareholders?: National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.09%), BlackRock Inc. (3.78%), Vanguard Group Inc. (3.45%), Conestoga Capital Advisors LLC (2.90%), Dimensional Fund Advisors LP (2.49%) and QV Investors Inc. (1.84%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, John N Nunnelly, Kevin R Karas and Steven D Jackson.
View institutional ownership trends.
How do I buy shares of National Research?: Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is National Research's stock price today?: One share of NRC stock can currently be purchased for approximately $37.77.
How much money does National Research make?: National Research (NASDAQ:NRC) has a market capitalization of $932.54 million and generates $147.95 million in revenue each year. The company earns $37.47 million in net income (profit) each year or $1.38 on an earnings per share basis.
How many employees does National Research have?: The company employs 511 workers across the globe.
How can I contact National Research?: National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061.

This page (NASDAQ:NRC) was last updated on 11/28/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial